Related Experiment Video
Updated: Jul 28, 2025

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence
Published on: February 10, 2023
APOBEC3B coordinates R-loop to promote replication stress and sensitize cancer cells to ATR/Chk1 inhibitors
Chunyan Zong1,2,3, Zhe Zhang1,2,3, Li Gao4
1Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Abstract:
The cytidine deaminase, Apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B, herein termed A3B), is a critical mutation driver that induces genomic instability in cancer by catalyzing cytosine-to-thymine (C-to-T) conversion and promoting replication stress (RS). However, the detailed function of A3B in RS is not fully determined and it is not known whether the mechanism of A3B action can be exploited for cancer therapy. Here, we conducted an immunoprecipitation-mass spectrometry (IP-MS) study and identified A3B to be a novel binding component of R-loops, which are RNA:DNA hybrid structures. Mechanistically, overexpression of A3B exacerbated RS by promoting R-loop formation and altering the distribution of R-loops in the genome. This was rescued by the R-loop gatekeeper, Ribonuclease H1 (RNASEH1, herein termed RNH1). In addition, a high level of A3B conferred sensitivity to ATR/Chk1 inhibitors (ATRi/Chk1i) in melanoma cells, which was dependent on R-loop status. Together, our results provide novel insights into the mechanistic link between A3B and R-loops in the promotion of RS in cancer. This will inform the development of markers to predict the response of patients to ATRi/Chk1i.
Insights
Apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) promotes cancer genomic instability by creating R-loops. Targeting this mechanism may enhance cancer therapy effectiveness.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- Apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B, A3B) is a known driver of cancer mutations.
- Its precise role in replication stress (RS) and potential therapeutic exploitation remain unclear.
Purpose of the Study:
- To elucidate the function of A3B in replication stress.
- To investigate whether A3B's mechanism can be targeted for cancer therapy.
Main Methods:
- Immunoprecipitation-mass spectrometry (IP-MS) was used to identify A3B binding partners.
- R-loop formation and distribution were analyzed upon A3B overexpression.
- The effect of Ribonuclease H1 (RNASEH1) on A3B-induced RS was assessed.
- Sensitivity to ATR/Chk1 inhibitors (ATRi/Chk1i) was evaluated in melanoma cells.
Main Results:
- A3B was identified as a novel binding component of R-loops.
- A3B overexpression exacerbated RS by promoting R-loop formation and altering their genomic distribution.
- Ribonuclease H1 (RNASEH1) rescued A3B-induced replication stress.
- High A3B levels correlated with sensitivity to ATRi/Chk1i in melanoma, dependent on R-loop status.
Conclusions:
- A3B promotes replication stress in cancer through R-loop formation.
- The findings reveal a mechanistic link between A3B, R-loops, and replication stress.
- This study provides a basis for developing biomarkers to predict patient response to ATRi/Chk1i therapy.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Restarting Stalled Replication Forks
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Anaphase Promoting Complex

